Targeted delivery of oligonucleotides using multivalent protein–carbohydrate interactions
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted delivery of oligonucleotides using multivalent protein–carbohydrate interactions
Authors
Keywords
-
Journal
CHEMICAL SOCIETY REVIEWS
Volume -, Issue -, Pages -
Publisher
Royal Society of Chemistry (RSC)
Online
2023-01-27
DOI
10.1039/d2cs00788f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mannose-6-phosphate glycan for lysosomal targeting: various applications from enzyme replacement therapy to lysosome-targeting chimeras
- (2022) Jinho Seo et al. Animal Cells and Systems
- Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease
- (2022) David A. Rider et al. ATHEROSCLEROSIS
- Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels
- (2022) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2
- (2022) Michelle A. Baum et al. KIDNEY INTERNATIONAL
- The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
- (2021) Benjamin A. H. Smith et al. NATURE REVIEWS DRUG DISCOVERY
- Human Lectins, Their Carbohydrate Affinities and Where to Find Them
- (2021) Cláudia D. Raposo et al. Biomolecules
- LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
- (2021) Green Ahn et al. Nature Chemical Biology
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
- (2021) Sander F. Garrelfs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, pharmacodynamics, and exposure-response modeling results from a first in human phase 1 study of nedosiran in primary hyperoxaluria.
- (2021) Bernd Hoppe et al. KIDNEY INTERNATIONAL
- Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
- (2021) Hao Cui et al. ACS Omega
- N-Acetyl Galactosamine Targeting: Paving the Way for Clinical Application of Nucleotide Medicines in Cardiovascular Diseases
- (2021) Erik A.L. Biessen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Randomized Clinical Trials Towards a Single‐Visit Cure for Chronic Hepatitis C: Oral GSK2878175 and Injectable RG‐101 in Chronic Hepatitis C Patients and Long‐Acting Injectable GSK2878175 in Healthy Participants
- (2020) Yanli Deng et al. JOURNAL OF VIRAL HEPATITIS
- Interfering with the Sugar Code: Ten Years Later
- (2020) Anna Bernardi et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Less is more: Novel hepatocyte-targeted siRNA conjugates for treatment of liver-related disorders
- (2020) Adrien Weingärtner et al. Molecular Therapy-Nucleic Acids
- Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
- (2020) Bahru A. Habtemariam et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Lysosome-targeting chimaeras for degradation of extracellular proteins
- (2020) Steven M. Banik et al. NATURE
- Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
- (2020) Manisha Balwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease
- (2020) Christine I. Wooddell et al. JCI Insight
- Multivalent, Stabilized Mannose‐6‐Phosphates for the Targeted Delivery of Toll‐Like Receptor Ligands and Peptide Antigens
- (2020) Niels R. M. Reintjens et al. CHEMBIOCHEM
- In Vivo siRNA Delivery to Immunosuppressive Liver Macrophages by α-Mannosyl-Functionalized Cationic Nanohydrogel Particles
- (2020) Leonard Kaps et al. Cells
- Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
- (2020) Muhammad Imran Sajid et al. Pharmaceuticals
- Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
- (2019) Eliane Sardh et al. NEW ENGLAND JOURNAL OF MEDICINE
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Multivalent Recognition at Fluid Surfaces: The Interplay of Receptor Clustering and Superselectivity
- (2019) Galina V. Dubacheva et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells
- (2019) Corwin M. Nycholat et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Design of Mannose-Functionalized Curdlan Nanoparticles for Macrophage-Targeted siRNA Delivery
- (2018) Tsogzolmaa Ganbold et al. ACS Applied Materials & Interfaces
- Mannose-functionalized Nanoscaffolds for Targeted Delivery in Biomedical Applications
- (2018) Jian Yin et al. Chemistry-An Asian Journal
- Galactose Multivalency Effect on the Cell Uptake Mechanism of Bioconjugated Nanoparticles
- (2018) Chumki Dalal et al. Journal of Physical Chemistry C
- Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
- (2017) Meike H van der Ree et al. LANCET
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Porphyria
- (2017) D. Montgomery Bissell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
- (2017) Yuanyu Huang Molecular Therapy-Nucleic Acids
- Well-Defined Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor
- (2016) Xiangang Huang et al. BIOCONJUGATE CHEMISTRY
- Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides
- (2016) Tsuyoshi Yamamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Biological roles of glycans
- (2016) Ajit Varki GLYCOBIOLOGY
- Comprehensive Structure–Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes
- (2016) Thazha P. Prakash et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of miR-21 by 3′/5′-Serinyl-Capped 2′-O-Methyl RNA Interspersed with 2′-O-(2-Amino-3-Methoxypropyl) Uridine Units
- (2016) Smita Nahar et al. Nucleic Acid Therapeutics
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
- (2015) Shigeo Matsuda et al. ACS Chemical Biology
- Efficient Synthesis and Biological Evaluation of 5′-GalNAc Conjugated Antisense Oligonucleotides
- (2015) Michael E. Østergaard et al. BIOCONJUGATE CHEMISTRY
- Solid-phase synthesis of 5′-triantennary N-acetylgalactosamine conjugated antisense oligonucleotides using phosphoramidite chemistry
- (2015) Thazha P. Prakash et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hepatocyte-Specific Delivery of siRNAs Conjugated to Novel Non-nucleosidic TrivalentN-Acetylgalactosamine Elicits Robust Gene Silencing in Vivo
- (2015) Kallanthottathil G. Rajeev et al. CHEMBIOCHEM
- Protein-Carbohydrate Interaction between Sperm and the Egg-Coating Envelope and Its Regulation by Dicalcin, a Xenopus laevis Zona Pellucida Protein-Associated Protein
- (2015) Naofumi Miwa MOLECULES
- Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
- (2015) Amy Chan et al. Molecular Therapy-Nucleic Acids
- Enhancement of Stability and Activity of siRNA by Terminal Substitution with Serinol Nucleic Acid (SNA)
- (2014) Yukiko Kamiya et al. CHEMBIOCHEM
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
- (2014) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- Liver-targeting of primaquine-(poly-γ-glutamic acid) and its degradation in rat hepatocytes
- (2013) Noboru Tomiya et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines
- (2013) Juan J. García-Vallejo et al. OncoImmunology
- Multivalent glycoconjugates as anti-pathogenic agents
- (2012) Anna Bernardi et al. CHEMICAL SOCIETY REVIEWS
- NMR study of ligand release from asialoglycoprotein receptor under solution conditions in early endosomes
- (2012) Takuo Onizuka et al. FEBS Journal
- Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169
- (2012) Weihsu C. Chen et al. PLoS One
- Plasticity of the asialoglycoprotein receptor deciphered by ensemble FRET imaging and single-molecule counting PALM imaging
- (2012) M. Renz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Letter to the Glyco-Forum: Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them
- (2011) A. Varki GLYCOBIOLOGY
- From lectin structure to functional glycomics: principles of the sugar code
- (2011) Hans-Joachim Gabius et al. TRENDS IN BIOCHEMICAL SCIENCES
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Endocytosis of nanomedicines
- (2010) Gaurav Sahay et al. JOURNAL OF CONTROLLED RELEASE
- In Silico Prediction of the 3D Structure of Trimeric Asialoglycoprotein Receptor Bound to Triantennary Oligosaccharide
- (2010) Sai Kumar Ramadugu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Structure, biological functions and applications of the AB5 toxins
- (2010) Travis Beddoe et al. TRENDS IN BIOCHEMICAL SCIENCES
- Microbial recognition of human cell surface glycoconjugates
- (2008) Anne Imberty et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now